intraocular lens Articles
-
The New Generation: Electronic IOLS
Restoring vision using a smart, active intraocular lens for cataract surgery SAV-IOL (Swiss Advanced Vision) is working towards the world’s first active, electronic intraocular lens implant for cataract surgery through the R-TASC Project. This new lens represents a real leap forward in vision restoration: smart, real-time autofocus. Current IOLs on the market suffer from optical ...
By SAV-IOL SA
-
Interactive revolution in eye care
Swiss Advanced Vision (SAV-IOL) is a Swiss manufacturer of high quality innovative intraocular lenses (IOLs) designed for cataract surgery. The company recently announced the start of a project for developing a revolutionary active intraocular lens, R-TASC (Real-Time Autofocus Servo Control), featuring real-time autofocus and wireless connectivity. Max Boysset, SAV-IOL CEO, believes R-TASC could ...
By SAV-IOL SA
-
Results of the United States Food and Drug Administration Clinical Trial of the CustomFlex Artificial Iris
Purpose To evaluate safety and efficacy of a custom-manufactured artificial iris device (CustomFlex Artificial Iris; HumanOptics AG) for the treatment of congenital and acquired iris defects. Design Multicenter, prospective, unmasked, nonrandomized, interventional clinical trial. Participants Patients with photophobia, sensitivity secondary to partial or complete congenital or acquired ...
-
Three Words: Simplicity, Quality, Performance
SAV-IOL’s Lucidis IOL combines the fantastic far vision and few photopic phenomena of a monofocal lens, with the added bonus of a high-quality extended depth-of-focus. In some respects, monofocal IOLs are hard to beat. Other than the obvious - a single focal plane - the drawbacks are few, and compared with the current crop of diffractive multifocal IOLs, they provide unparalleled distance ...
By SAV-IOL SA
-
New IOLS: Presbyopic Solutions and Toric Updates
As would be expected, monocular UDVA improved significantly from preoperative: 45% of eyes achieved 20/20 or better UDVA at 1 month postoperative. CDVA was 20/20 or better in 89% of eyes. Also at 1 month, monocular UIVA at 80 cm was 20/32 or better in 56% of eyes and 20/40 or better in 83% of eyes. DCIVA at 80 cm was 20/32 or better in 56% of eyes and 20/40 or better in 81%. DCIVA was also ...
By SAV-IOL SA
-
A Lens for All
Choose from over 3,000 configurations to find the perfect lens for each patient With a portfolio including the Eden and Lucidis premium IOLs, Swiss Advanced Vision (SAV-IOL) is already known for redrawing innovation boundaries in the IOL landscape. Now, the company is launching a system that brings customizable medicine to the world of cataract surgery. SAV-IOL’s unique offering comprises ...
By SAV-IOL SA
-
Medical Device Regulation - Indian Perspective
The Indian Medical Devices industry is mostly import-dependent with no specific regulations in place till recent times. With the introduction of MDR (Medical Device Rules 2017) attempt has been made to harmonize the Indian medical device Industry as per globally prevailed ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you